Jump to content
Toggle search
Toggle menu
  • 131 articles
  • 373 files
  • 34 users
  • 7K edits
Voror_Wiki
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Current data sets: Difference between revisions

From Voror_Wiki
More actions
← Older editNewer edit →

JoC (talk | contribs)

3 user groups
3,173 edits
VisualWikitext
No edit summary
No edit summary
Line 32: Line 32:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
Line 38: Line 38:
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
|'''✗'''
| style="color: red;" |'''✗'''
|-align="center"
|-align="center"
! scope="row"| Appointments
! scope="row"| Appointments
Line 46: Line 46:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: orange;" |'''✔'''
|'''✔'''
|-align="center"
|-align="center"
! scope="row"| Care episodes
! scope="row"| Care episodes
Line 65: Line 65:
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: orange;" |'''✔'''
| style="color: green;" |'''✔'''
|'''✔'''
| style="color: green;" |'''✔'''
|-align="center"
|-align="center"
! scope="row"| Diagnoses
! scope="row"| Diagnoses
Line 79: Line 79:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: orange;" |'''✗'''
| style="color: red;" |'''✗'''
|'''✔'''
| style="color: green;" |'''✔'''
|-align="center"
|-align="center"
! scope="row"| Documents
! scope="row"| Documents
Line 93: Line 93:
| style="color: orange;" | '''!'''
| style="color: orange;" | '''!'''
| style="color: orange;" | '''!'''
| style="color: orange;" | '''!'''
| style="color: red;" |'''!'''
| style="color: orange;" |'''!'''
|'''–'''
| style="color: grey;" |'''–'''
|-align="center"
|-align="center"
! scope="row"| Encounters/consultations
! scope="row"| Encounters/consultations
Line 107: Line 107:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: orange;" |'''✔'''
| style="color: green;" |'''✔'''
|'''✔'''
| style="color: green;" |'''✔'''
|-align="center"
|-align="center"
! scope="row"| Family history
! scope="row"| Family history
Line 116: Line 116:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
Line 122: Line 122:
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
|'''✗'''
| style="color: red;" |'''✗'''
|-align="center"
|-align="center"
! scope="row"| Follow ups/diary recall
! scope="row"| Follow ups/diary recall
Line 130: Line 130:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: red;" |'''–'''
| style="color: grey;" |'''–'''
|'''–'''
| style="color: grey;" |'''–'''
|-align="center"
|-align="center"
! scope="row"| Free text
! scope="row"| Free text
Line 150: Line 150:
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
|'''–'''
| style="color: grey;" |'''–'''
|-align="center"
|-align="center"
! scope="row"| Immunisations
! scope="row"| Immunisations
Line 158: Line 158:
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
Line 164: Line 164:
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
|'''✗'''
| style="color: red;" |'''✗'''
|-align="center"
|-align="center"
! scope="row"| Inpatient activity
! scope="row"| Inpatient activity
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''  
| style="color: green;" |'''✔'''  
| style="color: orange;" |'''✔'''
| style="color: green;" |'''✔'''
|'''✔'''
| style="color: green;" |'''✔'''
|-align="center"
|-align="center"
! scope="row"| Medication
! scope="row"| Medication
Line 191: Line 191:
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color: red;" |'''✗'''
| style="color:grey;" |'''✗'''
| style="color: red;" |'''✗'''
|'''✗'''
| style="color: red;" |'''✗'''
|-align="center"
|-align="center"
! scope="row"| Non-scheduled activity
! scope="row"| Non-scheduled activity
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color:grey;" |'''–'''
| style="color: grey;" |'''–'''
| style="color: green;" |'''✔'''
| style="color: green;" |'''✔'''
| style="color:grey;" |'''✔'''
| style="color:green;" |'''✔'''
|'''–'''
| style="color: grey;" |'''–'''
|-align="center"
|-align="center"
! scope="row"| Observations<ref>includes signs, symptoms, biological values, and pathology.</ref>
! scope="row"| Observations<ref>includes signs, symptoms, biological values, and pathology.</ref>
Line 220: Line 220:
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|-align="center"
|-align="center"
! scope="row"| Outpatient activity
! scope="row"| Outpatient activity
Line 233: Line 233:
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: orange;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
|'''&#10004;'''
| style="color: green;" |'''&#10004;'''
|-align="center"
|-align="center"
! scope="row"| Patient demographics
! scope="row"| Patient demographics
Line 247: Line 247:
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: orange;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
|'''&#10004;'''
| style="color: green;" |'''&#10004;'''
|-align="center"
|-align="center"
! scope="row"| Problems
! scope="row"| Problems
Line 256: Line 256:
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color:grey;" |'''&#8211;'''
| style="color: grey;" |'''&#8211;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
Line 262: Line 262:
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|-align="center"
|-align="center"
! scope="row"| Procedures
! scope="row"| Procedures
Line 270: Line 270:
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color:grey;" |'''&#8211;'''
| style="color: grey;" |'''&#8211;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color:grey;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
|-align="center"
|-align="center"
! scope="row"| Questions & answers
! scope="row"| Questions & answers
Line 290: Line 290:
| style="color:grey;" |'''&#8211;'''
| style="color:grey;" |'''&#8211;'''
| style="color:grey;" |'''&#8211;'''
| style="color:grey;" |'''&#8211;'''
|'''&#8211;'''
| style="color:grey;" |'''&#8211;'''
|-align="center"
|-align="center"
! scope="row"| Referrals
! scope="row"| Referrals
Line 303: Line 303:
| style="color:grey;" |'''&#8211;'''
| style="color:grey;" |'''&#8211;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: orange;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#10004;'''
| style="color: green;" |'''&#10004;'''
|-align="center"
|-align="center"
! scope="row"| Templates
! scope="row"| Templates
Line 318: Line 318:
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|-align="center"
|-align="center"
! scope="row"| Test orders
! scope="row"| Test orders
Line 326: Line 326:
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color:grey;" |'''&#8211;'''
| style="color: grey;" |'''&#8211;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color:grey;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
|-align="center"
|-align="center"
! scope="row"| Test results/Pathology results
! scope="row"| Test results/Pathology results
Line 340: Line 340:
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color:grey;" |'''&#8211;'''
| style="color: grey;" |'''&#8211;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''
| style="color: green;" |'''&#10004;'''  
| style="color: green;" |'''&#10004;'''  
| style="color: red;" |'''&#x2717;'''
| style="color: red;" |'''&#x2717;'''
| style="color:grey;" |'''&#x2717;'''
| style="color:red;" |'''&#x2717;'''
|'''&#x2717;'''
| style="color:red;" |'''&#x2717;'''
|-
|-
|}
|}

Revision as of 14:36, 5 September 2022

The following table shows the data sets that are currently published to the DDS by different supplier systems:

Data sets EMIS Web SystmOne Vision Adastra Cerner Millenium Silverlink Medway
Primary care GP Primary care community Primary care GP Primary care community Primary care GP Out of hours A&E Inpatient Outpatient ADT Feed ADT Feed Hospital
Allergies ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✗
Appointments ✔ ✔ ✔ ✔ ✗ – – – ✔ ✔ ✔ ✔
Care episodes ✔ ! ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
Diagnoses ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✗ ✗ ✔
Documents ✗ ✗ ✗ ✗ ✗ ✗ ! ! ! ! ! –
Encounters/consultations ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
Family history ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✗
Follow ups/diary recall ✔ ✔ ✔ ✔ ✗ – – – – – – –
Free text ? ? ✗ ✗ ✗ ✔ ✔ ✔ ✔ ✗ ✗ –
Immunisations ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✗
Inpatient activity – – – – – – ✔ ✔ – ✔ ✔ ✔
Medication ✔ ✔ ✔ ✔ ✔ ✔ ✗ ✗ ✗ ✗ ✗ ✗
Non-scheduled activity – – – – – ✔ ✔ – – ✔ ✔ –
Observations[1] ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✗ ✗ ✗
Outpatient activity – – – – – – – – ✔ ✔ ✔ ✔
Patient demographics ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
Problems ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✗
Procedures ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✔
Questions & answers – – – – – ✔ – – – – – –
Referrals ✔ ✔ ✔ ✔ ✔ – – – – ✗ ✗ ✔
Templates ✗ ✗ ✗ ✗ ✗ – ✗ ✗ ✗ ✗ ✗ ✗
Test orders ✗ ✗ ✗ ✗ ✗ – ✔ ✔ ✔ ✗ ✗ ✗
Test results/Pathology results ✔ ✔ ✔ ✔ ✔ – ✔ ✔ ✔ ✗ ✗ ✗

✔ = Data sets available and published to the DDS
✗ = Data sets available but not published to the DDS
? = Data sets applied for but not currently available
! = Data sets coming soon
– = Not applicable

Last update: 3 September 2020

Last review: 31 August 2022

See also: Current published data

Notes

  1. ↑ includes signs, symptoms, biological values, and pathology.
Retrieved from "https://wiki.voror.co.uk/index.php?title=Current_data_sets&oldid=6029"
Last modified
This page was last modified on 5 September 2022, at 14:36.